Sonoma Pharmaceuticals, Inc. announced that effective July 22, 2022, the Company's Board of Directors appointed Amy Trombly, Chief Executive Officer, to serve as a member of Board of Directors. Ms. Trombly will not receive additional compensation for her Board service. Ms. Trombly will serve as a Class I Director until the 2024 Annual Meeting of Stockholders.